Skip to main content
OpenTrials
Completed

NCT Number: NCT01475877

Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myopia Eye Diseases Refractive Errors

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Virdi Eye Clinic and Laser Vision Center

Rock Island, Illinois, 61201, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male or female at least 18 years of age,
  • no other ocular studies with 15 days prior to dosing,
  • BCVA 20/200 or better,
  • return for study visits and follow instructions from investigator and staff,
  • self administer test article

Exclusion criteria

  • Ocular inflammation,
  • hypersensitivity to bromfenac or nepafenac,
  • any corneal pathology,
  • have had radial keratotomy,
  • corneal transplant or corneal refractive surgery in the last two years

Treatment and study plan

bromfenac

Drug

Bromfenac 0.09% 1 drop in study eyes q day

Other names: Bromday

Primary outcomes

  1. Post-PRK pain

    Time frame: 7 days

Secondary outcomes

  1. Post-PRK epithelial healing

    Time frame: 7 days

Sponsors and collaborators

Lead sponsor

Virdi Eye Clinic

Other

Registry information

Official study title

Bromday (Bromfenac Ophthalmic Solution)0.09% QD vs Nevanac (Nepafenac Ophthalmic Suspension) 0.1% TID for Control of Pain and Epithelial Healing Post (PRK)

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Nov 21, 2011
Registry last updated
May 3, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.